Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Graham Scholefield

Latest From Graham Scholefield

Global Biopharma R&D Productivity And Growth Rankings

Catenion, a biopharma-focused R&D strategy consulting firm, has analyzed the performance of the top-30 biopharma companies in 2018 and outlined major concerns for the future of innovation in drug development. 

Innovation BioPharmaceutical

Methodology: R&D Productivity Ranking

To evaluate the R&D productivity of the world’s 30 largest public pharmaceutical companies, as judged by total pharmaceutical sales, Catenion takes an approach that focuses on value.

BioPharmaceutical

Biopharma R&D Productivity And Growth 2017: Big Pharma Closes The Gap

Catenion updates its annual list of the year's top pharma R&D performers. R&D productivity declined for the first time since 2014. Mid pharmas continue to dominate the top 10, but big pharmas are making inroads.

BioPharmaceutical Growth

Biopharma R&D Productivity And Growth 2016: Innovation Performance Improves

Catenion updates its annual list of the year's top pharma R&D performers, based on R&D productivity and growth. This year Regeneron shoots to the top and Gilead drops to third place.

Growth BioPharmaceutical

Methodology: R&D Productivity Ranking

To evaluate the R&D productivity of the world’s 30 largest public pharmaceutical companies, as judged by total pharmaceutical sales, Catenion's methodology takes an approach that focuses on value.

BioPharmaceutical

Value-Based R&D Pharma Productivity 2015: Oncology And Hep C Drive Top Performers

Catenion updates its annual list of the year's top pharma R&D performers, based on R&D productivity and growth.

BioPharmaceutical
See All
UsernamePublicRestriction

Register